Clinical Trials › NCT05003388
RecruitingPhase 1
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for MS
Sponsored by The Foundation for Orthopaedics and Regenerative Medicine
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 15
Target enrollment
Jun 2021
Start date
Oct 2025
Expected completion
Interventions / Treatments
AlloRx
Conditions studied
Multiple Sclerosis
Trial locations
U.S. site locations haven't been posted yet for this trial. Check ClinicalTrials.gov for the latest contact and location info.
